ChemEmbed: a deep learning framework for metabolite identification using enhanced MS/MS data and multidimensional molecular embeddings.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41686648.
- Also identified by DOI 10.1093/bib/bbag054 and PMC identifier 12903953.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Machine learning offers a promising path to annotating the large number of unidentified MS/MS spectra in metabolomics, addressing the limited coverage of current reference spectral libraries. However, existing methods often struggle with the high dimensionality and sparsity of MS/MS spectra and metabolite structures. ChemEmbed tackles these challenges by integrating multidimensional, continuous vector representations of chemical structures with enhanced MS/MS spectra. This enhancement is achieved by merging spectra across multiple collision energies and incorporating calculated neutral losses from 38 472 distinct compounds, providing richer input for a convolutional neural network (CNN). ChemEmbed ranks the correct candidate first in over 42% of cases and within the top five in more than 76% of cases. In external benchmarks such as CASMI 2016 and 2022, ChemEmbed outperforms SIRIUS 6, the current state-of-the-art in computational metabolomics. We applied ChemEmbed to predict structures in the Annotated Recurrent Unidentified Spectra (ARUS) dataset and confirmed 25 previously unidentified compounds. These findings demonstrate ChemEmbed's potential as a robust, scalable tool for accelerating metabolite identification in untargeted mass spectrometry workflows.
Medical subject headings
- Deep Learning
- Tandem Mass Spectrometry
- Metabolomics
- Software